Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

about

Identification of distinct molecular subtypes of uterine carcinosarcoma Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.Bladder Cancer: New Insights into Its Molecular Pathology.

P2860

Q37716634-B2DA2C5E-4F9F-46F5-9F54-67F646AF8725 Q39428933-BA10CF90-8D7E-4820-A9EC-49F440423BDA Q52609673-B7EEB22C-DF08-4518-8CA9-BF0A99862C5F

P2860

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

Item

http://www.wikidata.org/entity/Q36743446

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@ast

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@en

type

Item

label

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@ast

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@en

prefLabel

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@ast

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

@en

P1476

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma

@en

P2093

Elena Sala

http://www.w3.org/2001/XMLSchema#string

Giorgio Bovo

http://www.w3.org/2001/XMLSchema#string

Guido Strada

http://www.w3.org/2001/XMLSchema#string

Leda Dalprà

http://www.w3.org/2001/XMLSchema#string

Marialuisa Lavitrano

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise

Comprehensive molecular characterization of urothelial bladder carcinoma

Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.

Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells

DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.

Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

HER2 as a target in invasive urothelial carcinoma.

P304

271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS17030271

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Angela Bentivegna

Donatella Conconi

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295892125

http://www.w3.org/2001/XMLSchema#string

P698

26927059

http://www.w3.org/2001/XMLSchema#string

P932

4813135

http://www.w3.org/2001/XMLSchema#string

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

about

P2860

P2860

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932